What does Vertex Pharmaceuticals, Inc. do?

Jun 22 2025 06:06 PM IST
share
Share Via
Vertex Pharmaceuticals, Inc. focuses on discovering and commercializing medicines for serious diseases, primarily cystic fibrosis. As of March 2025, it reported net sales of $2.746 billion and a net profit of $646 million, with a market cap of approximately $113.5 billion.
Overview:
Vertex Pharmaceuticals, Inc. is engaged in discovering, developing, manufacturing, and commercializing medicines for serious diseases, primarily focusing on therapies for cystic fibrosis, and operates within the Pharmaceuticals & Biotechnology industry with a large-cap market valuation. Financial Snapshot: Most recent Net Sales: 2,746 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 646 Million (Quarterly Results - Mar 2025) Market cap: USD 113,501.78 Million (Large Cap) Key Metrics: P/E: NA Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.38 Return on Equity: -3.39% Price to Book: 6.88 Contact Details: Address: 50 Northern Ave, BOSTON MA: 02210-1862 Tel: ['1 617 3416393', '1 617 9616108'] Website: https://www.vrtx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read